Home › Funds › MASTERS CAPITAL MANAGEMENT LLC › BSX
MASTERS CAPITAL MANAGEMENT LLC position in BSX
BOSTON SCIENTIFIC CORP · Health Care
MASTERS CAPITAL MANAGEMENT LLC reported holding 250,000 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q2 2026 13F filing — a position valued at US$10.7M, representing 0.31% of its reported portfolio and ranking #45 among its reported holdings. MASTERS CAPITAL MANAGEMENT LLC has disclosed BSX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How MASTERS CAPITAL MANAGEMENT LLC's BSX position evolved
MASTERS CAPITAL MANAGEMENT LLC first disclosed a stake in BSX in Q1 2026 at 500,000 shares (US$31.4M). Across 2 filings, MASTERS CAPITAL MANAGEMENT LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 250,000 shares valued at US$10.7M — a reduction of -250,000 shares quarter over quarter.. Notable position changes include a 50% trim in Q2 2026 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 500.00K | $31.38M | New |
| Q2 2026 | 250.00K | $10.67M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- Banque Cantonale Vaudoise 67.61K sh · $2.89B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 50.52M sh · $2.16B · Q2 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- Janus Henderson Group 16.50M sh · $1.04B · Q1 2026
- Arrowstreet Capital 23.29M sh · $994.18M · Q2 2026
- Bollard Group LLC 18.42M sh · $786.20M · Q2 2026
More on MASTERS CAPITAL MANAGEMENT LLC
FAQ
How long has MASTERS CAPITAL MANAGEMENT LLC held BSX?
MASTERS CAPITAL MANAGEMENT LLC has disclosed BSX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is MASTERS CAPITAL MANAGEMENT LLC's current position in BSX?
As of Q2 2026, MASTERS CAPITAL MANAGEMENT LLC holds 250.00K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $10.67M, representing 0.31% of its reported portfolio and ranking #45.
Has MASTERS CAPITAL MANAGEMENT LLC been buying or selling BSX?
In the latest 13F filing (Q2 2026), MASTERS CAPITAL MANAGEMENT LLC reduced its position in BSX.
Which other funds hold BSX?
Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.